Oak Bay Biosciences
Victoria
About Oak Bay Biosciences
Oak Bay Biosciences is a biotechnology company that operates a portfolio of patents, molecules, and preclinical data to develop the first therapy for Stargardt disease in the market. Oak Bay Biosciences' lead molecule has the potential to avert blindness throughout a patient's lifetime, owing to its high potency, durability, and prolonged half-life in the eye.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Seed (May 2022)
- Website: oakbaybio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/oak-bay-biosciences-120520 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.